Hetty Jolink

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Ribavirin post-exposure prophylaxis for Andes virus exposure: a viewpoint.

Ribavirin post-exposure prophylaxis for Andes virus exposure: a viewpoint.

Journal: EBioMedicine
Published: May 24, 2026

The immunogenicity of pneumococcal conjugate vaccinations in patients with asplenia and hyposplenia: a systematic review.

The immunogenicity of pneumococcal conjugate vaccinations in patients with asplenia and hyposplenia: a systematic review.

Journal: NPJ vaccines
Published: February 16, 2026

Severe neurological complications of leptospirosis, presentation of two cases.

Severe neurological complications of leptospirosis, presentation of two cases.

Journal: IDCases
Published: October 16, 2025

Correction to: Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.

Correction to: Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.

Journal: Journal of clinical immunology
Published: October 09, 2025

Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.

Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.

Journal: Journal of clinical immunology
Published: December 17, 2024

Simultaneous Protein Quantitation and Glycosylation Profiling of Antigen-Specific Immunoglobulin G1 in Large Clinical Studies.

Simultaneous Protein Quantitation and Glycosylation Profiling of Antigen-Specific Immunoglobulin G1 in Large Clinical Studies.

Journal: Journal of proteome research
Published: November 13, 2024

Case report: Persistent hypogammaglobulinemia and mixed chimerism after HLA class-II disparate-hematopoietic stem cell transplant.

Case report: Persistent hypogammaglobulinemia and mixed chimerism after HLA class-II disparate-hematopoietic stem cell transplant.

Journal: Frontiers in immunology
Published: March 07, 2024

Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.

Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.

Journal: Frontiers in immunology
Published: February 22, 2024

Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity.

Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity.

Journal: Journal of clinical immunology
Published: January 03, 2023

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.

Journal: The Journal of allergy and clinical immunology
Published: January 20, 2022

Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance.

Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance.

Journal: Medical mycology
Published: May 18, 2021

B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review.

B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review.

Journal: Frontiers in immunology
Published: April 02, 2021
Showing 1-12 of 17

Last Updated: 09/26/2026